Nachrichten zur ASTRAZENECA PLC DL-,25 Aktie

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Astrazeneca nach einer Analystenkonferenz während des diesjährigen Europäischen…

LumiraDx surges after partnering with AstraZeneca, Everton on Englands first heart and lung screening hub…

…

Dublin, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The "Medical Courier Market Size and Forecasts 2020-2030, Global and Regional…

Press release Nanoform Finland Plc October 23, 2023 08:10 Finnish time / 07:10 Swedish time Nanoform grant Global STARMAP[®] AI License to AstraZeneca Helsinki, Finland…

LONDON, Oct. 20, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care diagnostics company,…

…

New York (www.aktiencheck.de) - Rating-Update: Seamus Fernandez, Analyst von Guggenheim Securities, stuft die Aktie des Pharmakonzerns AstraZeneca plc (ISIN: GB0009895292, WKN:…

…

NIH data show that globally less than 2% of genetic information being studied today originates from people of African ancestry1…

AstraZeneca shares fall as abstract for lung cancer trial data disappoints…

Shares in AstraZeneca fell more than 4% on Wednesday after the publication of an abstract on its experimental precision drugs…

The FDA accepts and grants priority review to AstraZenecas (AZN) sNDA, seeking approval of Tagrisso combined with chemotherapy as a…

[235 + Pages Report] According to a market research study published by The Brainy Insights, the demand analysis of Global…

MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.R&D Postdoctoral Challenge ist eine einzigartige Initiative…

Todays Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Chevron Corporation (CVX) and…

…

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Astrazeneca auf "Hold" mit einem Kursziel von 11000 Pence…

Gruppe um Air France-KLM steigt bei skandinavischer Airline SAS einAstraZeneca hat sich bereit erklärt, 425 Mio USD zu zahlen, um…

Despite overall biologic growth in both geographies, use of advanced systemic treatments in the US outpaces the EU5. Despite overall…

Company to Host Cancer R&D Update on October 19, 2023 to Share Latest Details of Multipronged Cancer Program Based on…

DJ Astrazeneca legt Nexium- und Prilosec-Klagen gegen Millionenzahlung bei Von Michael Susin FRANKFURT (Dow Jones)--Der Pharmakonzern Astrazeneca legt US-Produkthaftungsklagen im…

AstraZeneca to pay $425 million to settle Nexium, Prilosec litigation in US…

3 October 2023 AstraZeneca settles Nexium and Prilosec product liability litigations AstraZeneca has entered into settlement agreements in the product liability litigations related to Nexium and Prilosec. The agreements…

2 October 2023 15:00 BST Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

A deadline looms to sign drug-price negotiation agreements as industry watches for legal reprieve.…

The dynamics of the eosinophilic esophagitis market are anticipated to change in the coming years owing to the expected launch…

AstraZeneca, Boehringer Ingelheim and other drugmakers have filed at least eight lawsuits seeking to declare the Medicare price talks unconstitutional.…

[230+ Pages Report] According to a market research study published by The Brainy Insights, the demand analysis of Global…

AstraZeneca is the largest foreign owned pharmaceutical company in China based on revenue, and they’re continuing to increase investment in…

…

The dynamics of the chronic obstructive pulmonary disease market are anticipated to change in the coming years owing to the…

AstraZeneca growth opportunities overlooked - Jefferies…

These are the stocks posting the largest moves in early trading.…

Analyst Peter Welford said that Astrazenecas R&D assets outside the oncology pipeline can offer "significant upside optionality."…

NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat Astrazeneca von "Hold" auf "Buy" hochgestuft…

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat Astrazeneca von "Hold" auf "Buy" hochgestuft und das Kursziel von 10500…

Daiichi Sankyo Co. shares jumped by the most in a year after a drug it developed with AstraZeneca Plc showed…

A Centers for Disease Control and Prevention advisory committee on Friday recommended pregnant people get Pfizer Inc.’s PFE maternal vaccine…

These are the stocks posting the largest moves before the bell.…

…

Activision Blizzard, AstraZeneca, Scholastic, Faraday Futures, Alibaba and NIO were the most active stocks ahead of Fridays market open.…

This announcement contains inside information 22 September 2023 Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with…

© Foto: Pexels/ Polina TankilevitchEin milliardenschwerer Pharma-Deal sorgt an der Börse für Furore: AstraZeneca übernimmt Pfizers Gentherapie-Portfolio für seltene Krankheiten!…

AstraZeneca refused to pay full bonus to US remote worker, lawsuit claims…

An der Börse liegt der Anteilsschein von AstraZeneca aktuell im Plus. Das Wertpapier notiert derzeit bei 68,29 US-Dollar. Ein Kursgewinn…

Eine entsprechende Kauf- und Lizenzvereinbarung sei abgeschlossen worden, teilte der britisch-schwedische Pharmakonzern mit. Mit dem Erwerb wolle AstraZeneca auf…

Die Aktie von AstraZeneca ist aktuell der größte Gewinner im Nasdaq 100 . Das Aktienbarometer gibt derzeit lediglich 0,03 Prozent…

Leading dextromethorphan market players include AstraZeneca plc, FibroGen, Inc., Novartis AG, Abbott Laboratories, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Merck…

Eine entsprechende Kauf- und Lizenzvereinbarung sei abgeschlossen worden, teilte der britisch-schwedische Pharmakonzern mit. Mit dem Erwerb wolle AstraZeneca auf…